BB Biotech (Switzerland) Probability of Future Stock Price Finishing Over 37.97
| BION Stock | CHF 37.35 0.20 0.54% |
BION |
BB Biotech Target Price Odds to finish over 37.97
The tendency of BION Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over ₣ 37.97 or more in 90 days |
| 37.35 | 90 days | 37.97 | about 20.66 |
Based on a normal probability distribution, the odds of BB Biotech to move over ₣ 37.97 or more in 90 days from now is about 20.66 (This BB Biotech AG probability density function shows the probability of BION Stock to fall within a particular range of prices over 90 days) . Probability of BB Biotech AG price to stay between its current price of ₣ 37.35 and ₣ 37.97 at the end of the 90-day period is about 21.73 .
Assuming the 90 days trading horizon BB Biotech has a beta of 0.92 suggesting BB Biotech AG market returns are correlated to returns on the market. As the market goes up or down, BB Biotech is expected to follow. Additionally BB Biotech AG has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. BB Biotech Price Density |
| Price |
Predictive Modules for BB Biotech
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as BB Biotech AG. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.BB Biotech Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. BB Biotech is not an exception. The market had few large corrections towards the BB Biotech's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold BB Biotech AG, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of BB Biotech within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.19 | |
β | Beta against Dow Jones | 0.92 | |
σ | Overall volatility | 0.99 | |
Ir | Information ratio | -0.16 |
BB Biotech Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of BB Biotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for BB Biotech AG can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| BB Biotech AG generated a negative expected return over the last 90 days | |
| BB Biotech AG has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (404.81 M) with profit before overhead, payroll, taxes, and interest of 4 K. | |
| BB Biotech AG has accumulated about 2.83 M in cash with (94.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 65.76, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
BB Biotech Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of BION Stock often depends not only on the future outlook of the current and potential BB Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. BB Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 55.4 M | |
| Cash And Short Term Investments | 2.8 M |
BB Biotech Technical Analysis
BB Biotech's future price can be derived by breaking down and analyzing its technical indicators over time. BION Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of BB Biotech AG. In general, you should focus on analyzing BION Stock price patterns and their correlations with different microeconomic environments and drivers.
BB Biotech Predictive Forecast Models
BB Biotech's time-series forecasting models is one of many BB Biotech's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary BB Biotech's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about BB Biotech AG
Checking the ongoing alerts about BB Biotech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for BB Biotech AG help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| BB Biotech AG generated a negative expected return over the last 90 days | |
| BB Biotech AG has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (404.81 M) with profit before overhead, payroll, taxes, and interest of 4 K. | |
| BB Biotech AG has accumulated about 2.83 M in cash with (94.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 65.76, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Additional Tools for BION Stock Analysis
When running BB Biotech's price analysis, check to measure BB Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BB Biotech is operating at the current time. Most of BB Biotech's value examination focuses on studying past and present price action to predict the probability of BB Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BB Biotech's price. Additionally, you may evaluate how the addition of BB Biotech to your portfolios can decrease your overall portfolio volatility.